Natavan Alikhanova
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 6
- HIV/AIDS drug development and treatment 1
-
- HIV, Drug Use, Sexual Risk 2
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Infectious Diseases and Tuberculosis 1
- Diagnosis and treatment of tuberculosis 1
-
- HIV, TB, and STIs Epidemiology 2
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Sabira TahseenS. M. Mostofa KamalDaniela María CirilloMatteo ZignolAnna DeanAlena SkrahinaNazir IsmailAndrea Maurizio Cabibbe
- Journals
- Journal of Clinical Microbiology (1 paper)PLoS Medicine (1 paper)European Respiratory Journal (1 paper)
- Partner nations
- United StatesSouth AfricaItaly
In The Last Decade
Natavan Alikhanova
7 papers receiving 165 citations
Peers
Comparison fields: 5 of 32
- Infectious Diseases 160
- Epidemiology 125
- Molecular Medicine 10
- Surgery 44
- Applied Microbiology and Biotechnology 2
Countries citing papers authored by Natavan Alikhanova
This map shows the geographic impact of Natavan Alikhanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natavan Alikhanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natavan Alikhanova more than expected).
Fields of papers citing papers by Natavan Alikhanova
This network shows the impact of papers produced by Natavan Alikhanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natavan Alikhanova. The network helps show where Natavan Alikhanova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Natavan Alikhanova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2020 | 41 | |
| 3 | 2020 | 80 | |
| 4 | 2018 | 27 | |
| 5 | 2018 | 2 | |
| 6 | Characteristics and Treatment Outcomes of New Pulmonary Tuberculosis Patients with Comorbidities in the Samarkand Region, Uzbekistan | 2016 | 1 |
| 7 | 2014 | 11 |
About Natavan Alikhanova
Natavan Alikhanova is a scholar working on General Social Sciences, Infectious Diseases and Epidemiology, having authored 7 papers that have together received 169 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), HIV, Drug Use, Sexual Risk (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), HIV, TB, and STIs Epidemiology (2 papers), Cancer therapeutics and mechanisms (1 paper), Infectious Diseases and Tuberculosis (1 paper), HIV/AIDS drug development and treatment (1 paper) and Diagnosis and treatment of tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (160 citations), Epidemiology (125 citations) and Molecular Medicine (10 citations). Natavan Alikhanova has collaborated with scholars based in United States, South Africa and Italy. Frequent co-authors include Sabira Tahseen, S. M. Mostofa Kamal, Daniela María Cirillo, Matteo Zignol, Anna Dean, Alena Skrahina, Nazir Ismail, Andrea Maurizio Cabibbe, Claudio U. Köser and Philippe Glaziou. Their work appears in journals such as Journal of Clinical Microbiology, PLoS Medicine and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.